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Multiple different genetic defects can lead to the lossofconstitutive class II MHC
(la) expression in B cells (1). Somaticcell hybridization between spontaneous or ex-
perimentally selected human Ia- mutant B cell lines have divided the class II MHC
expression mutants into at least three complementation groups. The defect in one
such Ia mutant cell line, RJ 2.2.5, has been postulated to be in a positive transacting
factor that is active across species, because it is complemented by a locus, a1r-1, that
maps to mousechromosome 16 (2). Class II Ea and DQ(3upstream cis-active DNA
elements transfected into RJ 2.2.5 cells do not act as transcriptional elements (3,
4). Nevertheless, these DNA motifs appear tobind nuclearfactors in RJ 2.2.5 indis-
tinguishable from those in thewild-typeparent Raji. Thus, the absence ofa positive
transacting factor in RJ 2.2.5 could not be correlated with the absence of a DNA
binding activity for a class fI gene.
We recently determined the 5' upstream region of the murine MHC class II EO
gene that is necessaryforconstitutive Ea expression in murine B cells (5). This 126-
bp sequence contains three consensus elements, W X, and Y(6), that are highly
conserved in evolution. The W X, Y sequence functions as a tissue-specific tran-
scriptional element that is exclusively active in MHC class II-positive cells. In mu-
rine nuclear extracts, there are two distinct protein complexes termed complex A
and complex B that bind the WX, Y sequence. ComplexB may be similar toprevi-
ously identified CCAAT box-binding proteins NRY orYBl (7, 8), and its presence
does not correlatewith constitutive or induced class II expression. ComplexA, how-
ever, appeared to be novel, and is present in nuclear extracts of murine cells that
express MHC class II genes. Here we examine complex A activity in extracts from
normal and class 11-deficient human B cells.
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Materials and Methods
BriefDefinitive Report
Cell Cultures and Transfections.
￿
Culture medium andcellshave allpreviously been described
(2, 5, 9). Txls5cl7 (Txl) is a secondary transfectant of RJ 2.2.5 cells stably transfected with
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M12.4.1 DNA, and is classII positive (10). The cells were all transfected by the DEAE-dextran
method and chloramphenicolacetyl transferase (CAT) activity assayed at 48 h after transfec-
tion, as described (11).
Plasmid Constructions and Oligonucleotides.
￿
The pH-H is a plasmid that contains 130 by of
E(3 upstream sequence containing W, X, and Y consensus motifs subcloned into the Sma
I site of pUC 18 (11). The constructs used for CAT assays are depicted in Fig. 1 and reference
11. The oligonucleotides used for binding and competition, and their purification, are de-
scribed elsewhere (9, 11).
Electromobility Shift Electrophoresis Assay (EMSA).
￿
Preparation of nuclear extracts was by
a modification ofthe method ofDignam (12), and EMSA assays were performed as described
(9). The Hae fragment probe (Hae) was generated by digesting pH-H with Barn HI, end
labeled with [732p)ATP and polynucleotide kinase, digested with Eco RI, and isolated by
gel electrophoresis. For EMSA analysis, a total sample of 10 JAI included 1 ng oflabeled probe
(10,000 cpm), 2-4 Wg of protein from nuclear extract, and 4 jug of poly dI-dC (Pharmacia
Fine Chemicals, Piscataway, NJ) as a nonspecific competitor. Samples for competition anal-
ysis were processed as for EMSA, except that the nuclear extracts were preincubated with
water or competitor DNA for 5 min at room temperature before addition of labeled probe.
Results and Discussion
RJ 2.2.5 is a mutant of the class II-positive cell Raji, which was generated by
,y irradiation and negative immunoselection (2). Although the RJ 2 .2.5 cells have
lost class II expression, their class II structural genes are intact, since fusion to an
Ia' mouse cell restores human class II. Further studies of these hybrids have
identified a locus on mouse chromosome 16, aIr-1, that complements the defect in
these human cells (2) . Since the RJ 2 .2 .5 mutant lacks a non-species-specific trans-
acting factor, it was ofinterest to determine ifthe 126-bp-positive element containing
W, X, and Y sequences (-192 to -66 relative to the transcription start site) was
active in these cells. To investigate this further, it was necessary to determine whether
the 126-bp element of murine origin could function in human cells. For this pur-
pose, the human class II-positive parental cell line Raji was transfected with plasmid
constructs containing 5' upstream sequences ofthe murine E/3 gene fused to the CAT
gene (Fig. 1). Fig. 1, Lanes 3 and 4 demonstrate that constructscontaining the three
conserved motifs W, X, and Y, whether contained within a 2.6-kbconstruct (-2679
to -66) or in a 126-bp (-192 to -66) construct, are expressed in human B cells.
Interestingly, the same constructs transfected into the class II-negative mutant of
Raji, Rj 2.2.5, do not express above the enhancerless control plasmid (Fig. 1, lanes
7 and 8). Furthermore, constructs containing individual W, X, or Y motifs alone
do not enhance CAT activity in Raji and RJ 2.2.5 cells (not shown). These data
suggest that all three conserved motifs are necessary to function as a positive tran-
scription element in human B cells, consistent with our earlier data in murine B
cells. This positive element does not function in human class II-negative mutant
cell line.
To determine whether there was a difference in factors binding to any of the in-
dividual motifs, W X, or Y, each of the individual motifs was used as a labeled
target in an EMSA (Fig. 2). Comparison of extracts from the la- RJ 2 .2 .5 (Fig. 2,
lanes 2, 4, and 6) cells with the Ia' Raji cells (Fig. 2, lanes 1, 3, and 5) demon-
strates that there is no difference in factors binding to W, X, or Y motifs between
these two cell lines. These results are consistent with work from other laboratoriesFINN ET AL .
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FIGURE 1 . Expression of E,B
WXY constructs in the Raji
and Txl, butnot the RJ 2.2.5,
cell line . E,gd-CAT constructs as
depicted were assayed forCAT
activity in a transient transfec-
tion assay . Thenumbers for the
constructs correspond to the
portion of the sequence in the
germ line E/4 upstream sequence.
Each transfection was per-
formed aminimumof five times
anda representativeexperiment
is shown . Fold activity represents
the average CAT activity of at
least three independent experi-
ments over the CAT activity of
the enhancerless control, pA10
cat2 . The cells transfected are
Raji (lanes 1-4), RJ 2.2 .5 (lanes
5-8), and Txl (lanes 9-12) . The
constructs transfected arePSV2
CAT (lanes 1, 5, and 9), pA10
cat2 (lanes 2, 6, and 10),
-2679 to -66 (lanes 3, 7, and
11), -192 to -66 (lanes 4, 8,
and 12) .
that demonstrated no difference in factors from RJ 2 .2.5 or Raji cell extracts binding
to the X and Y motif of the Ea and DQ# genes (3, 4) .
To determinewhethercomplexA exists inhuman as well as murine cells, nuclear
extracts from the human class II-positive Raji were examined in an EMSA using
a labeled fragment containing the W, X, Y consensus sequence (Hae) as the target
probe (Fig . 3 A) . Comparison of nuclearextracts from two murine class H-positive
B cells, M12.4 .1 andA20 (Fig . 3 A, lanes 1 and 2), with the Raji extract (Fig. 3 A,
lane 3), shows that two retarded bands are noted, complexAand B, that migrate
FIGURE 2 . No difference in factors
binding to individualW X, and Y
motifsbetween Raji andRJ 2.2 .5 cells .
EMSA with end-labeled oligonucleo-
tide probes corresponding to theESW
(lanes 1 and 2), X (lanes 3and 4), or
Y (lanes 5 and 6) -conserved motifs.
Raji extract (lanes 1, 3, and5);RJ 2.2 .5
extract (lanes 2, 4, and 6).2162
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FIGURE 3 .
￿
(A) ComplexA is
present in an Ia'human B cell,
absent in an Ia - mutant, and
reappears in the la' Txl cell .
EMSA ofnuclear extracts from
M12.4.1 (lane 1), A20 (lane 2),
Raji (lane 3), Rj 2.2.5 (lane 4),
and Txl cells (lane 5) . Theprobe
is the end-labeled Hae frag-
ment . (B) Competition ofcom-
plex A formation in extracts
from human Raji cells . The
competitors are unlabeled ho-
mologous sequence (Hae) (lanes
2 and 3), YEO motif (YE/3)
(lanes3and 4), and irrelevant
competitor corresponding to the
X boxofthe human DZa gene
(DZa) (lane 6) .
at the same position in all three cell lines . The complexes in human extracts bind
specificDNA sequences because their formation is prevented by unlabeledhomolo-
gous sequence (Fig . 3 B, lanes 2 and 3), but not by 100-fold molar excess of irrele-
vant sequence (Fig . 3 B, lane 6) . ComplexA is most efficientlycompeted by an unla-
beled homologous sequence that contains all three motifs (Fig. 3 B, lanes 2 and 3),
whileW X, or Y sequences tested individually have little effect (not shown) . Foot-
print analysis shows that complex A from nuclear extracts from Raji cells protects
the conserved Y motif (not shown), similar to what we had observed with extracts
from murine macrophages and B cells (5, 11) .
We next asked whether the correlation between the presence of complex A and
class II expression extended to the human class II-negative cellRj 2.2.5 . An EMSA
(Fig . 3 A, lane 4) demonstrates that complex A is absent in Rj 2.2 .5 extracts, in
contrast to the pattern seen with the parental Raji (Fig . 3 A, lane 3) . To ask whether
the defect in class II expression in the Rj 2.2.5 cells was related to the inability to
form complex A, the Txl cell line was used . Txl cells are derivatives ofRj 2.2.5 cells
that have been stably transfected with mouse genomicDNA resulting in restoration
ofthe human class II-positive status (10) . Ifloss ofclass II expression in the Rj 2.2.5
cell is related to the absence of complex A, then restoration of the class II-positive
status should be accompanied by complexA formation as well . EMSA with nuclear
extracts from Txl cells (Fig . 3 A, lane 5) indeed demonstrates the reappearance of
complexA. In addition, complex A from extracts from Txl cells has the identical
footprint pattern as is observed with extracts from Raji cells (not shown) . Moreover,
cis-active transcription activity of the W, X, and Y element is restored in the Txl
cell line (Fig. 1, lanes 11 and 12), concomitant with restoration of class II expression
and complex A formation .
This is the first demonstration that the Ia- Rj 2.2.5 cell lacks a DNA-binding
protein complex and fails to utilize the W, X, and Y transcriptional element, both
ofwhichcorrelatewith the loss of class IIMHC expression (compare Fig. 1 B, lanes
3 and 4 with 7 and 8) . Restoration of both class II expression and complex A, as
well as transcriptional activity of the targetWXY sequence in the Txl cell line (Fig .FINN ET AL.
￿
BRIEF DEFINITIVE REPORT
￿
2163
3 A, lane 5; and Fig. 1, lanes 11 and 12), points to a pivotal role for complex A
or factors that control complex A in driving class II gene transcription. Thus, there
are several lines ofevidence that demonstrate a strong correlation between the pres-
ence of complex A and MHC class II expression. First, complex A is absent in ex-
tracts from a human class II-negative cell, RJ 2 .2 .5; second, complex A reappears
in the human class II-positive Txl cell line; third, complex A is present in extracts
from murine class II-positive cells; fourth, we have recently shown that complex
A is related to the level ofla expression during the development ofthe B cell lineage,
and finally, complex A formation occurs both in nuclear extracts from macrophages
exposed to IFN--y, as well as in pre-B cells exposed to IL-4 (5, 11). Therefore, we
propose that the mutation in RJ 2.2 .5 is a defect in the complex A factor(s) or in
another factor that regulates complex A formation.
Summary
An E(3 DNA protein complex termed complex A, whose binding activity has re-
cently been shown to correlate with both constitutive and regulated class II expres-
sion in murine cell lines, is also present in a human B cell, Raji. The DNA involved
in complex A, which includes three previously defined transcriptional motifs, W
X, and Y, is a cis-acting transcription element in Raji cells. Both complex A binding
activity and transcriptional activity of its target sequence are absent in an la- mu-
tant subclone of Raji, RJ 2.2.5. This cell line, whose defect is complemented by a
locus on mouse chromosome 16, reexpresses both class II and complex A upon trans-
fection with mouse genomic DNA. We suggest that factors that form complex A
or that regulate complex A formation account for the molecular lesion in this cell line.
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